Thakkar, Vivek
Patterson, Karen A.
Stevens, Wendy
Wilson, Michelle
Roddy, Janet
Sahhar, Joanne
Proudman, Susanna
Hissaria, Pravin
Nikpour, Mandana
Funding for this research was provided by:
Scleroderma Australia
Arthritis Australia
Actelion Pharmaceuticals
Bayer
CSL Biotherapies
GlaxoSmithKline Australia
Pfizer Australia
National Health and Medical Research Council (APP1126370)
Article History
Received: 21 December 2017
Revised: 15 March 2018
Accepted: 23 March 2018
First Online: 23 April 2018
Compliance with ethical standards
:
: Vivek Thakkar has received honoraria for speaking from Actelion and has been on advisory boards for Actelion and GSK. The co-authors declare that they have no conflicts of interest.